Article

Cataract controversies addressed by leading surgeons

New Orleans-Leading cataract surgeons agree that the introduction of the clear cornea incision (CCI) offers advantages with respect to surgical efficiency and visual recovery, and they also recognize that there has been a recent increase in the rate of postcataract surgery endophthalmitis. However, the role of the CCI in the rising infection incidence is more controversial.

Speaking at "Spotlight on Cataracts 2004: Cataract Controversies", Peter J. McDonnell, MD, presented data from an extensive, systematic review of the English language literature and analysis of the Medicare database to demonstrate that the occurrence of postcataract surgery endophthalmitis has increased in the United States in recent years. While he noted that pattern is temporally associated with the introduction and increased use of the CCI, Dr. McDonnell acknowledged there is no proof for a causal relationship.

However, he also presented evidence from two studies performed at Wilmer Eye Institute-one in the laboratory using eye bank eyes and the other in the surgical setting-to demonstrate a mechanism by which the CCI might allow ingress of contaminated ocular surface fluid into the anterior chamber.

"We believe that attention should be directed to acquiring better understanding of both the dynamics of clear cornea incisions in the early postoperative period and the mechanism for the rising incidence of endophthalmitis," Dr. McDonnell said.

Speaking in defense of the CCI that he introduced, I. Howard Fine, MD, emphasized that acquiring skill in performing that incision involves a learning curve, and its potential for risk depends on how well the incision is done.

"We have performed 7,000 cases of cataract surgery with a clear cornea incision over the last 8 years without a single case of endophthalmitis and don't think that record is due to good luck. I am not here to sell the clear cornea incision, as I believe surgeons should use whatever incision they can perform with the most reproducibly safe results. Clearly, however, not all clear cornea incisions are the same," Dr. Fine said.

He raised questions about the clinical relevance of the methods used in the studies Dr. McDonnell described. In addition, Dr. Fine suggested that changing bacterial resistance to the antibiotics used for cataract surgery prophylaxis may be another contributing factor to the recent increasing incidence of endophthalmitis.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.